Uhlenhuth EH, Balter MB, Ban TA, Yang K: International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders. J Affect Disord, 1995, 35. vsk, nro 4, s. 153–62. PubMed:8749980doi:10.1016/0165-0327(95)00064-XISSN 0165-0327
Uhlenhuth EH, Balter MB, Ban TA, Yang K: Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. Eur Neuropsychopharmacol, 1999, 9 Suppl 6. vsk, s. S393–8. PubMed:10622685doi:10.1016/S0924-977X(99)00050-4
Uhlenhuth EH, Balter MB, Ban TA, Yang K: International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. J Clin Psychopharmacol, 1999, 19. vsk, nro 6 Suppl 2, s. 23S–29S. PubMed:10587281doi:10.1097/00004714-199912002-00005
Bruce SE, Vasile RG, Goisman RM, et al: Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry, 2003, 160. vsk, nro 8, s. 1432–8. PubMed:12900305doi:10.1176/appi.ajp.160.8.1432
nih.gov
pubmed.ncbi.nlm.nih.gov
Uhlenhuth EH, Balter MB, Ban TA, Yang K (1999). "International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997". Depress Anxiety 9 (3): 107–16. PubMed:10356648.
Uhlenhuth EH, Balter MB, Ban TA, Yang K: International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders. J Affect Disord, 1995, 35. vsk, nro 4, s. 153–62. PubMed:8749980doi:10.1016/0165-0327(95)00064-XISSN 0165-0327
Uhlenhuth EH, Balter MB, Ban TA, Yang K: Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. Eur Neuropsychopharmacol, 1999, 9 Suppl 6. vsk, s. S393–8. PubMed:10622685doi:10.1016/S0924-977X(99)00050-4
Uhlenhuth EH, Balter MB, Ban TA, Yang K: International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. J Clin Psychopharmacol, 1999, 19. vsk, nro 6 Suppl 2, s. 23S–29S. PubMed:10587281doi:10.1097/00004714-199912002-00005
Stevens JC, Pollack MH: Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. J Clin Psychiatry, 2005, 66 Suppl 2. vsk, s. 21–7. PubMed:15762816
Bruce SE, Vasile RG, Goisman RM, et al: Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry, 2003, 160. vsk, nro 8, s. 1432–8. PubMed:12900305doi:10.1176/appi.ajp.160.8.1432
Uhlenhuth EH, Balter MB, Ban TA, Yang K: International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders. J Affect Disord, 1995, 35. vsk, nro 4, s. 153–62. PubMed:8749980doi:10.1016/0165-0327(95)00064-XISSN 0165-0327